0QF:FRA
Moderna Inc
€171.08
arrow_upward
+1.28%(+2.16) 1D
Oct 2, 9:21:43 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
€169.66
High
€171.08
Low
€169.66
Mkt. cap
75.43B
Avg. vol.
2.99K
Volume
562.00
52-wk high
€183.40
52-wk low
€19.26
No. of employees
5K
Open
€169.66
High
€171.08
Low
€169.66
Mkt. cap
75.43B
Avg. vol.
2.99K
Volume
562.00
52-wk high
€183.40
52-wk low
€19.26
No. of employees
5K
News stories
From web sources and news partners
TradingView
·
1 hour ago
SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
Investing.com
·
2 hours ago
Moderna to replace Warner Bros Discovery on Nasdaq 100 By Reuters
Yahoo Finance
·
8 hours ago
Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026
Barchart.com
·
17 hours ago
Why Citi Is Sounding the Alarm on Moderna Stock
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
About Moderna Inc